SCHEMBL1978514

SCHEMBL1978514

CN(C)C(=O)c1ccc(OCCCN2C[C@H]3CC[C@H]3C2)cc1

nearest known ligand 0.64

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 11/20 0.64
HRH2 P25021 1/20 0.52
HRH1 P35367 1/20 0.52
GPR119 Q8TDV5 6/20 0.52
TBXAS1 P24557 1/20 0.50
MAOB P27338 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1977490 0.99 HRH3 (0.62) HRH3HRH2HRH1GPR119TBXAS1
SCHEMBL2023640 0.96 HRH3 (0.59) HRH3HRH2HRH1GPR119TBXAS1
Hydrochloric Acid SCHEMBL1979118 0.95 HRH3 (0.58) HRH3HRH2HRH1GPR119TBXAS1
SCHEMBL4493848 0.95 HRH3 (0.68) HRH3HRH2HRH1GPR119TBXAS1
SCHEMBL4489369 0.95 HRH3 (0.72) HRH3HRH2HRH1GPR119TBXAS1
SCHEMBL3824760 0.92 HRH3 (0.57) HRH3HRH2HRH1GPR119TBXAS1
Oxalic Acid SCHEMBL4485952 0.92 HRH3 (0.67) HRH3HRH2HRH1GPR119MAOB
SCHEMBL4465038 0.89 HRH3 (0.53) HRH3GPR119TBXAS1
SCHEMBL2027296 0.88 HRH3 (0.69) HRH3HRH2HRH1MAOB
Hydrochloric Acid SCHEMBL1978511 0.86 HRH3 (0.68) HRH3HRH2HRH1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332910-B1 New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them SERVIER LAB (FR) 2013-01-30 EP claimed
US-8008337-B2 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-08-30 US claimed
EP-2332910-A1 New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2011-06-15 EP claimed
US-20110136886-A1 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-06-09 US claimed
EP-2332910-B1 New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them SERVIER LAB (FR) 2013-01-30 EP disclosed
US-8008337-B2 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-08-30 US disclosed
EP-2332910-A1 New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2011-06-15 EP disclosed
US-20110136886-A1 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136886-A1 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them HRH2, HRH4, HRH3 HRH3 3/4885HRH2 1/4885HRH1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.